Lead, Pricing & Planning Americas Market Access, Global Rare Diseases

About UsBased in Parma, Italy, Chiesi is an international research-focused biopharmaceutical group with 90 years’ experience, operating in 31 countries. More than 8,000 employees across the group are united by a singular purpose: promoting a healthier world for our people, patients, and the planet. This is what drives us as we research, develop, and market innovative drugs across our main therapeutic areas. Discover more here.At Chiesi we are thinking generations ahead, driving sustainable innovation with purpose. This fosters a culture of reliability, transparency, and ethical behaviour at every level. As a Benefit Corporation and a certified B Corp, we have embedded sustainability in our bylaws and continuously measure our impact. Diversity, inclusion, and equal opportunity are at the heart of who we are. We believe our differences make us stronger. We are a vibrant ecosystem of passionate, talented individuals united by strong values, each bringing unique perspectives that help us to continuously challenge the status quo for the better. Chiesi Global Rare DiseasesChiesi Global Rare Diseases is a Chiesi Group’s business unit established in February 2020 and focused on research, development and commercialization of treatments and patient support services for rare and ultra-rare disorders, many of whom have limited or no treatments available.This unit is based in Boston, Massachusetts, with a strong synergy with the headquarters in Parma. Rare unit has a focus on research and product development for lysosomal storage diseases, rare hematology, ophthalmology disorders and rare immunodeficiencies. The unit is also a dedicated partner with global leaders in scientific research, patient advocacy and care. Discover more here.Who we are looking forThis is what you will doThe Lead, Pricing & Planning, Global Rare Diseases will serve as the Market Access strategic partner for the Rare Disease portfolio, ensuring that payer, contracting, and reimbursement insights are effectively integrated into business cases, pricing strategies, and commercialization plans for the full Chiesi GRD portfolio (8-10 reimbursed products). This role focuses on shaping GTN‑relevant assumptions and interpreting GTN outputs in close collaboration with FP&A and Government Pricing.This high impact role will also be responsible for the development and implementation of strategic, cross-functional business cases, ensuring alignment with global commercialization strategies for the full Chiesi GRD portfolio (8-10 reimbursed products). Reporting to the Head of Contracting, Forecasting, Pricing, Americas Market Access, Global Rare Diseases, this role provides subject‑matter expertise on contracting strategy, reimbursement trends, and marketplace shifts that influence GTN outcomes. The Lead will translate these insights into strategic recommendations, scenario inputs, and cross‑functional business cases aligned with global commercialization strategies for the Chiesi GRD portfolio. They will also partner closely with FP&A to embed these recommendations into budget cycles, forecasts, and long‑range planning models., GRD scenario planning, and GRD forecasting in partnership with FP&A, Market Access, Patient Services and Government Pricing. You will undertake various modelling and scenario planning analyses to drive financial accuracy in alignment with FP&A cycles for budgeting and forecasting. This role is critical to integrating the dynamics of the marketplace and government policies into financial performance.As a leader within the Market Access team, you will also assist in building Market Access related business cases related to the optimization of our discounting strategy through the formulation of insights and assumptions for the GRD portfolio. This will require an extensive knowledge of Chiesi’s HUB services, trade & distribution strategy, and the reimbursement landscape for various therapeutics areas.This is a strategic and management role leveraging your understanding of the global and US health care systems, competitive insights, and clinical understanding, to determine opportunities where we can drive value for Chiesi and our patients.You’ll be responsible for:Partner with FP&A to provide critical assumptions pertaining to payer mix, contracting, and reimbursement insights that inform GTN assumptions for the Rare Disease portfolio. Conduct long term business assessments of commercial/government contracting proposals on pricing and reimbursement for GRD products, providing routine updates at leadership forums to guide insightful decisions.Lead the development of county pricing proposals and strategic Market Access business cases for Chiesi’s Rare Diseases portfolio in the USA, LATAM and Canada.Lead cross-functional projects with stakeholders from FP&A, Market Access Strategy & HEOR, Patient Services, and Analytics to provide better insights on claims/rebate data integrity, evaluate payer mix/GTN analogues for new product launches/lifecycle, and effectiveness of our specialty pharmacy/hub offerings.Engage with key stakeholders from the GRD Commercial brand teams, Patient Support Services, Finance and the Analytics team to address market access questions pertinent to business needs.Leverage existing FP&A/GTN reporting and support further reporting initiatives to provide insights and recommendations to the GRD Leadership Team to optimize GTN for the GRD portfolio of products.Contribute to the development of specific market access strategies and monitor country implementation with regional/global stakeholders within US, LATAM & Canada, ensuring GRD objectives are protected in launch & maximizes the value for our patients.Support the development of materials for the US Pricing Committee to secure the approval of the respective business cases.Actively monitor for changes to the modus operandi in the healthcare marketspace, monitoring pricing and access trends such as 340B policies, threats & opportunities, and present findings to senior management as required.Coordinate and oversee projects with external consultants as needed.Communicate frequently and effectively with GRD leadership and other identified stakeholders on the progress of existing and new initiatives.You will need to haveBachelor’s Degree in a quantitative discipline required (e.g., Engineering, Statistics, Economics, Finance).12+ years of US pharmaceutical industry experience with increasing responsibilities preferably in a Commercial or Market Access function.4+ years of experience in developing US pricing, reimbursement and contracting strategies.Proven track record of designing and implementing business cases that translates channel pricing and reimbursement strategies into reality.Experienced in leading and managing cross-functional teams and working closely with senior management.Excellent working knowledge of the evolving US Pricing & Reimbursement dynamics, with understanding of the US health system environment (e.g., Integrated Delivery Networks, Specialty Pharmacies, Mail Order/Retail Pharmacies, 340B Contract Pharmacies) for specialty, rare and transformative therapies.Working knowledge and familiarity with syndicated Market Access databases such as IQVIA, MMIT and other pricing/reporting tools such as Model N, pricing compendia and 852/867 datasets.Experience leading a cross-functional team or initiative is required, with the ability to influence decision-makers through insightful analysis and persuasive communication.Strong analytical and business acumen – intellectual curiosity and ability to structure problems, diagnose issues and triangulate with multiple approaches while keeping sight of the “big picture”.Self-directed and confident, with ability to contribute to shared commitment and goals to achieve high standards of performance.Ability to successfully manage multiple tasks and cross-functional stakeholders with a high attention to detail, while navigating changing priorities or timelines.Proficient in MS Office, specifically Excel. Additional experience working with analysis or other data reporting tools preferred (such as QlikView or PowerBI).We would prefer for you to haveMaster’s Degree in a quantitative discipline (e.g., Engineering, Statistics, Economics, Finance).LocationHybrid position based in Boston, MA office. #LI-HybridCompensationThe annual base pay for this position ranges from $181,140 to $225,060. Hourly and salaried non-exempt employees will also be paid overtime pay when working qualifying overtime hours. Base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience. If hired, the employee will be in an “at-will position” and the Company reserves the right to modify base pay (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors. What we offerNo matter where your path starts at Chiesi, it leads to inspiring possibilities. Your future is our focus, and we are committed to nurturing your development in our dynamic, friendly environment with access to resources and training every step of the way.We provide top-class benefits, including comprehensive healthcare programs, work-life balance initiatives, and robust relocation support. Our salary package is competitive, comprising a basic salary, performance bonuses, and benefits benchmarked against the external market. Additionally, we offer flexible working arrangements, remote work options, and tax assistance services for foreign colleagues, all designed to help you thrive.Chiesi USA is an equal opportunity employer committed to hiring a diverse work force at all levels of our business. All qualified applicants receive consideration for employment without regard to race, national origin, age, sex, religion, disability, marital status, veteran status, or any other basis protected by local, state or federal law. This policy applies with regard to all aspects of one’s employment, including hiring, transfer, promotion, compensation, eligibility for benefits and termination.